APP and Alzheimer disease: In an APP/PS1 transgenic AD mouse model, intranasal transplantation of human NSCs results in the differentiation of cholinergic neurons, which reduces amyloid accumulation by upregulating amyloid degrading enzymes, and neprilysin expression reduce neuroinflammation, pericytic and synaptic loss, and restores cognitive function.